Scleroderma is one of the features of Mixed Connective Tissue Disease (MCTD). The majority of people with Scleroderma also have symptoms of Raynaud's Phenomenon. A chronological series of HBOT case studies and research covering these conditions is arranged below. Unfortunately, the majority of the research on Scleroderma and Raynaud's using HBOT was performed in Russia and most do not have translations on PubMed. Anyone able to source or translate the Russian studies is encouraged to contact us.
Joint disorders that cause pain and stiffness through inflammatory or degenerative changes.
Changes in spinal discs that may contribute to back or neck pain, stiffness and reduced function.
An autoimmune condition in which the pancreas produces little or no insulin, requiring lifelong insulin therapy.
A chronic condition causing widespread pain, fatigue, sleep disturbance and increased sensitivity.
Chronic inflammatory bowel diseases that can cause abdominal pain, diarrhea, bleeding and fatigue.
An immune-mediated disease of the brain and spinal cord that can affect movement, sensation, vision and energy.
A chronic immune-mediated skin condition causing inflamed, scaly plaques that may flare and remit.
A rare inflammatory skin disorder causing rapidly developing, painful ulcers, often on the legs.
Connective-tissue and vascular disorders that can affect skin, circulation, joints and internal organs.
Severe reactions that cause widespread blistering, skin loss and injury to mucous membranes.
.svg)